drugIndia
Cart
Already at best price
Glycomet Trio Forte 1 Tablet SR

Glycomet Trio Forte 1 Tablet SR

Glimepiride (1mg) + Voglibose (0.2mg) + Metformin (1000mg)

USV Ltd
Inflammatory
125.76157.2020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
125.7620% OFF
157.20

About This Medicine

Product description & overview

Glycomet Trio Forte 1 Tablet SR

Glycomet Trio Forte 1 Tablet SR is a comprehensive medication specifically designed to help manage type 2 diabetes. This once-daily formulation combines the potent actions of three key ingredients:

* Glimepiride (1mg): A sulfonylurea that effectively stimulates insulin release from the pancreas.
* Metformin (1000mg): A first-line medication for blood sugar control, it works by reducing glucose production in the liver and increasing cellular uptake of glucose.
* Voglibose (0.2mg): This unique ingredient provides an extra layer of action by slowing down the breakdown of carbohydrates into glucose after consumption.

This combination offers a convenient and effective solution for individuals struggling with type 2 diabetes, aiding in achieving optimal blood sugar control and managing associated symptoms. Always consult your healthcare provider for personalized treatment recommendations before starting or altering any medication regimen.

Important: This description is not a substitute for professional medical advice. Never self-medicate.

Active composition

Glimepiride 1 mg

+2 more active ingredients

About Glimepiride

Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.

How It Works

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Medicine Strength
1 mg

All Active Ingredients

Glimepiride1 mg
Voglibose0.2 mg
Metformin1000 mg

Voglibose

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Metformin

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glycomet Trio Forte 1 Tablet SR.

High Risk

Pregnancy

Glycomet Trio Forte 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glycomet Trio Forte 1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glycomet Trio Forte 1 Tablet SR may be needed. Please consult your doctor. Glycomet Trio Forte 1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glycomet Trio Forte 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glycomet Trio Forte 1 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glycomet Trio Forte 1 Tablet SR is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Glycomet Trio Forte 1 Tablet SR

Products matching your search